cercosporamide has been researched along with Carcinoma, Hepatocellular in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, S; Liu, Y; Su, X; Sun, L | 1 |
1 other study(ies) available for cercosporamide and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Inhibition of eukaryotic initiation factor 4E phosphorylation by cercosporamide selectively suppresses angiogenesis, growth and survival of human hepatocellular carcinoma.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzofurans; Carcinoma, Hepatocellular; Cell Proliferation; Cell Survival; Cisplatin; Dose-Response Relationship, Drug; Drug Synergism; Eukaryotic Initiation Factor-4E; Hep G2 Cells; Humans; Intracellular Signaling Peptides and Proteins; Liver Neoplasms; Mice, SCID; Neovascularization, Pathologic; Phosphorylation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Signal Transduction; Time Factors; Transfection; Xenograft Model Antitumor Assays | 2016 |